血乳酸和D-二聚体的测定对感染性休克的预后评估(2)
 |
| 第1页 |
参见附件(1287KB，2页)。
[参考文献]
[1]YU SY.Critical Care Monitoring and Therapy[M]. Beijing:Beijing Medical University,Peking Union College United Press,1998:403.
[2]周成杰,陈国忠,安敏飞,等.感染性休克动脉血乳酸水平及乳酸清除率与APACHE Ⅱ评分相关性分析[J].浙江实用医学,2008,13(6):410-411.
[3]Fuloria M.Elevated plasma lactate levels:a tool for predicting outcomes or for improving care[J].Crit Care Med,2002,30(9):2166-2167.
[4]Husain FA,Martin MJ,Mullenix PS,et al.Serum lactate and base deficit as predictors of mortality and morbidity[J].AmJSurg,2003,185(5):485-491.
[5]Henning RJ,Wei MN,Weiner F.Blood lactate as a prognostic indicator of survivial in patients with acute myocardial infarction[J].Circ Shock,1982, 11(3-4):141.
[6]许丽,李春盛,庞宝森，等.危重病患者可溶性血管细胞粘附分子-1及乳酸的变化[J].中国危重病急救医学,2002,14(8):499.
[7]李政霖,李元忠，郭玉梅.乳酸水平和APACHE Ⅲ对ICU危重患者预后临床评价的应用比较[J].承德医学院学报,2007,24(1):17.
[8]Gando S,Nanzaki S,Sasaki S,et al.Activation of the extrinsic coagulation pathway in patientswith severe sep sis and sep tic shock[J].Crit CareMed,1998,26:2005-2009.
[9]Querol-Ribelles JM,Tenias JM,Grau E,et al.Plasma d-dimer levels correlate with outcomes in patientswith community-acquired pneumonia [J]. Chest,2004,126(4):1087-1092.
(收稿日期：2010-04-02)
您现在查看是摘要介绍页，详见PDF附件(1287KB，2页)。